FDA's "Act Now" Philosophy Has Drawbacks For Industry - CHPA Exec

FDA's current speed in taking action sometimes sacrifices fair treatment of industry and can fail to allow for logistical realities, according to OTC stakeholders

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet